Healthcare Infection Control Practices Advisory Committee (HICPAC), 16334 [2014-06455]
Download as PDF
<![CDATA[
16334
Federal Register / Vol. 79, No. 57 / Tuesday, March 25, 2014 / Notices
in, an entity is required to provide their
Data Universal Numbering System
(DUNS) number. FSRS then pulls core
data about the entity from their System
for Award Management (SAM)
registration to include the legal business
name, physical address, mailing address
and Commercial and Government Entity
(CAGE) code. The entity completes the
FSRS registration by providing contact
information within the entity for
approval.
If a prime awardee has already
registered in FSRS to report contractsrelated Transparency Act financial data,
a new log-in will not be required. In
addition, if a prime awardee had a user
account in the Electronic Subcontract
Reporting System (eSRS), a new log-in
will not be required.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention (CDC)
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Subcommittee on Procedures Review,
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting for the
aforementioned committee:
Respondents: 1,844.
Responses Per Respondent: 1.
Total annual responses: 1,844.
Hours Per Response: .5.
Total Burden Hours: 922.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the General Services Administration,
Regulatory Secretariat Division (MVCB),
1800 F Street NW., Washington, DC
20405, telephone 202–501–4755. Please
cite OMB Control No. 3090–0291, FSRS
Registration Requirements for Prime
Grant Awardees, in all correspondence.
Times and Dates: 9:00 a.m.–5:00 p.m.,
April 10, 2014.
9:00 a.m.–12:00 p.m., April 11, 2014.
Place: CDC Global Communications
Center, Building 19, Auditorium B3, 1600
Clifton Road NE., Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available. Please register for the
meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with
providing advice and guidance to the
Director, Division of Healthcare Quality
Promotion, the Director, National Center for
Emerging and Zoonotic Infectious Diseases
(NCEZID), the Director, CDC, the Secretary,
Health and Human Services regarding (1) the
practice of healthcare infection prevention
and control; (2) strategies for surveillance,
prevention, and control of infections,
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) periodic updating of CDC guidelines and
other policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters for Discussion: The agenda will
include updates on the Draft Guideline to
Prevent Surgical Site Infections, CDC and
Division of Healthcare Quality Promotion’s
(DHQP’s) activities for prevention and
surveillance of healthcare associated
infections (HAI), core infection prevention
and control practices and the Draft Health
Care Personnel guideline.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Erin
Stone, M.S., HICPAC, Division of Healthcare
Quality Promotion, NCEZID, CDC, 1600
Clifton Road, NE., Mailstop A–07, Atlanta,
Georgia 30333 Telephone (404) 639–4045.
Email: hicpac@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: March 18, 2014.
Sonny Hashmi,
Deputy Chief Information Officer, Office of
the Deputy CIO.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–06555 Filed 3–24–14; 8:45 am]
[FR Doc. 2014–06455 Filed 3–24–14; 8:45 am]
BILLING CODE 6820–XY–P
BILLING CODE 4163–18–P
B. Public Comments
Public comments are particularly
invited on: Whether this collection of
information is necessary for the proper
performance of functions of the FSRS
Registration Requirements for Prime
Grant Awardees, whether it will have
practical utility; whether our estimate of
the public burden of this collection of
information is accurate, and based on
valid assumptions and methodology;
ways to enhance the quality, utility, and
clarity of the information to be
collected; and ways in which we can
minimize the burden of the collection of
information on those who are to
respond, through the use of appropriate
technological collection techniques or
other forms of information technology.
A 60-day notice, requesting comments
was published in the Federal Register at
78 FR 79454 on December 30, 2013, no
comments were received.
C. Annual Reporting Burden
emcdonald on DSK67QTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Mar<15>2010
18:16 Mar 24, 2014
Jkt 232001
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned subcommittee:
Time And Date: 11:00 a.m.–5:00 p.m., EST,
April 16, 2014.
Place: Audio Conference Call via FTS
Conferencing. The USA toll-free, dial-in
number is 1–866–659–0537 and the pass
code is 9933701.
Status: Open to the public. The public is
welcome to submit written comments in
advance of the meeting, to the contact person
below. Written comments received in
advance of the meeting will be included in
the official record of the meeting. The public
is also welcome to listen to the meeting by
joining the teleconference at the USA tollfree, dial-in number, 1–866–659–0537 and
the passcode is 9933701.
Background: The ABRWH was established
under the Energy Employees Occupational
Illness Compensation Program Act of 2000 to
advise the President on a variety of policy
and technical functions required to
implement and effectively manage the
compensation program. Key functions of the
ABRWH include providing advice on the
development of probability of causation
guidelines that have been promulgated by the
Department of Health and Human Services
(HHS) as a final rule; advice on methods of
dose reconstruction which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2015.
Purpose: The ABRWH is charged with (a)
providing advice to the Secretary, HHS, on
the development of guidelines under
Executive Order 13179; (b) providing advice
to the Secretary, HHS, on the scientific
validity and quality of dose reconstruction
efforts performed for this program; and (c)
upon request by the Secretary, HHS,
providing advice to the Secretary on whether
there is a class of employees at any
Department of Energy facility who were
E:\FR\FM\25MRN1.SGM
25MRN1
]]>Agencies
[Federal Register Volume 79, Number 57 (Tuesday, March 25, 2014)]
[Notices]
[Page 16334]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-06455]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting for the aforementioned
committee:
Times and Dates: 9:00 a.m.-5:00 p.m., April 10, 2014.
9:00 a.m.-12:00 p.m., April 11, 2014.
Place: CDC Global Communications Center, Building 19, Auditorium
B3, 1600 Clifton Road NE., Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Please register for the meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion,
the Director, National Center for Emerging and Zoonotic Infectious
Diseases (NCEZID), the Director, CDC, the Secretary, Health and
Human Services regarding (1) the practice of healthcare infection
prevention and control; (2) strategies for surveillance, prevention,
and control of infections, antimicrobial resistance, and related
events in settings where healthcare is provided; and (3) periodic
updating of CDC guidelines and other policy statements regarding
prevention of healthcare-associated infections and healthcare-
related conditions.
Matters for Discussion: The agenda will include updates on the
Draft Guideline to Prevent Surgical Site Infections, CDC and
Division of Healthcare Quality Promotion's (DHQP's) activities for
prevention and surveillance of healthcare associated infections
(HAI), core infection prevention and control practices and the Draft
Health Care Personnel guideline.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Erin Stone, M.S., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton
Road, NE., Mailstop A-07, Atlanta, Georgia 30333 Telephone (404)
639-4045. Email: hicpac@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2014-06455 Filed 3-24-14; 8:45 am]
BILLING CODE 4163-18-P
